Equities

SoftOx Solutions AS

  • Add to watchlist
  • Add to portfolio
  • Add an alert

SoftOx Solutions AS

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (NOK)0.1235
  • Today's Change-0.011 / -7.84%
  • Shares traded59.52m
  • 1 Year change+41.40%
  • Beta1.3743
Data delayed at least 15 minutes, as of Jul 01 2025.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

On Tuesday, SoftOx Solutions AS (SOFTX:OSL) closed at 0.1235, -29.23% below its 52-week high of 0.1745, set on May 12, 2025.
52-week range
Today
0.01Jan 20 20250.1745May 12 2025
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open0.13
High0.14
Low0.1165
Bid0.1205
Offer0.1235
Previous close0.134
Average volume36.02m
Shares outstanding2.24bn
Free float1.15bn
P/E (TTM)--
Market cap300.22m NOK
EPS (TTM)-0.0257
NOK
Data delayed at least 15 minutes, as of Jul 01 2025.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.